Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

167.55 -3.14 (-1.84%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	748,617
Open	168.97
Bid (Size)	167.36 (1,100)
Ask (Size)	167.58 (1,700)
Prev. Close	170.69
Today's Range	165.75 - 170.59
52wk Range	79.19 - 184.40
Shares Outstanding	47,190,970
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Biotech Is Heating Up—These 2 Red-Hot Stocks Stand Out ↗

Today 8:23 EST

Via MarketBeat

2 Healthcare Stocks to Buy for 2026 and Beyond ↗

Today 5:35 EST

These could be the next biotech giants.

Via The Motley Fool

Performance

YTD	-6.2%	-6.2%
1 Month	+13.5%	+13.5%
3 Month	+41.1%	+41.1%
6 Month	+49.1%	+49.1%
1 Year	+100.0%	+100.0%

More News

Regencell Bioscience (RGC) Stumbles into 2026: 8% Year-End Slide Sparks Technical Caution

January 01, 2026

Via MarketMinute

Here are the top movers in Wednesday's session. ↗

December 31, 2025

Via Chartmill

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

Why Axsome Therapeutics Stock Rocketed Higher to End 2025 ↗

December 31, 2025

Via The Motley Fool

The market is filled with gapping stocks in Wednesday's session. ↗

December 31, 2025

Via Chartmill

Axsome Advances Toward FDA Filing For Drug To Treat Narcolepsy ↗

December 31, 2025

Via Stocktwits

Axsome Therapeutics Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for AXS-05 for the Treatment of Alzheimer’s Disease Agitation

December 31, 2025

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-12 in Narcolepsy Supporting NDA Submission

December 31, 2025

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Beyond AI: How Non-AI Tech Innovations are Fueling a New Era of Stock Market Growth

December 11, 2025

Via MarketMinute

2 Under-the-Radar Stocks to Buy Heading Into 2026 ↗

December 01, 2025

Via The Motley Fool

Axsome (AXSM) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Via The Motley Fool

Axsome Therapeutics to Participate in Upcoming Investor Conferences

November 20, 2025

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Axsome Therapeutics, Inc. Common Stock - AXSM

November 10, 2025

From Pomerantz LLP

Via GlobeNewswire

2 Monster Stocks in the Making ↗

November 10, 2025

Via The Motley Fool

Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy

November 06, 2025

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Axsome Therapeutics Inc (NASDAQ:AXSM) Q3 2025 Earnings: Revenue Beat Overshadowed by Wider-Than-Expected Loss ↗

November 03, 2025

Via Chartmill

Axsome Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

November 03, 2025

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Uncovering Potential: Axsome Therapeutics's Earnings Preview ↗

October 31, 2025

Via Benzinga

Halper Sadeh LLC Encourages Axsome Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights

October 24, 2025

From Halper Sadeh LLC

Via Business Wire

Axsome Therapeutics to Participate in Upcoming Investor Conferences

October 22, 2025

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community

October 09, 2025

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Axsome Therapeutics to Report Third Quarter 2025 Financial Results on November 3

October 07, 2025

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years ↗

September 30, 2025

Via The Motley Fool

Frequently Asked Questions

Is Axsome Therapeutics, Inc. - Common Stock publicly traded?

Yes, Axsome Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Axsome Therapeutics, Inc. - Common Stock trade on?

Axsome Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Axsome Therapeutics, Inc. - Common Stock?

The ticker symbol for Axsome Therapeutics, Inc. - Common Stock is AXSM on the Nasdaq Stock Market

What is the current price of Axsome Therapeutics, Inc. - Common Stock?

The current price of Axsome Therapeutics, Inc. - Common Stock is 167.55

When was Axsome Therapeutics, Inc. - Common Stock last traded?

The last trade of Axsome Therapeutics, Inc. - Common Stock was at 01/08/26 04:00 PM ET

What is the market capitalization of Axsome Therapeutics, Inc. - Common Stock?

The market capitalization of Axsome Therapeutics, Inc. - Common Stock is 7.91B

How many shares of Axsome Therapeutics, Inc. - Common Stock are outstanding?

Axsome Therapeutics, Inc. - Common Stock has 8B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.